For SEC62, these data confirmed our previously reported findings for a smaller cohort of HNSCC patients, in which we analyzed SEC62 expression in tissue specimens of the primary tumor [27]. This evidence concerns the gene SEC62 and head and neck squamous cell carcinoma.